Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

11.11.2019 back forward

Ebola Vaccine Authorised

Ebola virus (Source: Cynthia Goldsmith / CDC)

In June 2019, the European Commission grants marketing authorisation to an Ebola vaccine for the first time. The Paul-Ehrlich-Institut supported the development of the Ebola vaccine, from clinical trials by way of marketing authorisation through to batch testing. Based on this data, WHO prequalifies the vaccine in November 2019. This prequalification is an important prerequisite for the use of the vaccine in countries most at risk of Ebola outbreaks. The Ebola vaccine has already been used successfully in the Congo.

Vaccine for the Fight Against Ebola